Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tempo and mode of inhibitor-mutagen antiviral therapies: a multidisciplinary approach.

Proceedings of the National Academy of Sciences of the United States of America - 20 Sept 2011

Iranzo Jaime, Perales Celia, Domingo Esteban, Manrubia Susanna C

Abstract excerpt

The continuous emergence of drug-resistant viruses is a major obstacle for the successful treatment of viral infections, thus representing a persistent spur to the search for new therapeutic strategies. Among them, multidrug treatments are currently at the forefront of pharmaceutical, clinical, and computational investigation. Still, there are many unknowns in the way that different drugs interact among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Dose-Response Relationship, Drug

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Foot-and-Mouth Disease Virus

Share to Guanidine

Share to Mutagens

Share to Ribavirin

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 21911373
DOI: 10.1073/pnas.1110489108
PMCID: PMC3179121

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tempo and mode of inhibitor-mutagen antiviral therapies: a multidisciplinary approach.PMID 21911373Read ↗

Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.Semantic proximity Read ↗

HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection.Semantic proximity Read ↗

Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus.Semantic proximity Read ↗

Mechanisms of action of ribavirin against distinct viruses.Semantic proximity Read ↗

Mutation rate and the efficacy of antimicrobial drug treatment.Semantic proximity Read ↗

Development of a stochastic model for the efficacy of NRTIs using known mechanisms of action.Semantic proximity Read ↗

Clinical mechanism of ribavirin action in Hepatitis C treatment: insights from the STOPHCV-1 randomised trialSemantic proximity Read ↗

Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.Semantic proximity Read ↗

Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.Semantic proximity Read ↗

Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin.Semantic proximity Read ↗

Murine norovirus (MNV-1) exposure in vitro to the purine nucleoside analog Ribavirin increases quasispecies diversity.Semantic proximity Read ↗

Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.